BBC article features Simmaron!
Read all about us!
BBC reporter Dr. David Cox interviewed our Chief Scientific Officer Avik Roy, PhD about Simmaron’s treatment trial of rapamycin and our scientific research on disease mechanisms in ME and Long-Covid.
Published yesterday, Long Fatigue: The exhaustion that lingers after an infection is a BBC – Future story about Long-Covid, ME/CFS and the biological search to understand and treat post-infectious symptoms. The article is great exposure for the science in our disease, and the need for much more.
Read the excerpts about us!
““’Viral infections may trigger long-term and persistent impairment in one’s immune system,’ says Avik Roy, chief scientific officer at the non-profit Simmaron Research, which conducts research into the treatment of neuroimmune diseases. ‘Autoimmune responses due to the altered behaviour of immune cells such as T lymphocytes, natural killer cells and macrophages may cause damage in the myelin layer of peripheral nerves, resulting in muscle weakness and fatigue.’”
“Simmaron Research along with the Mayo Clinic and the Center for Chronic Diseases, have launched a clinical trial of low-dose rapamycin in people with ME/CFS to see whether it can improve mitochondrial function and quality of life by stimulating a key bodily process called autophagy, encouraging cells to remove and recycle damaged components. ‘So far, the trial has produced very promising initial results,’ says Roy.””
Hats off to our sharp, laser-focused science team, led by Dr. Avik Roy and Dr. Gunnar Gottschalk!
We couldn't do it without our collaborators of excellence at UW-Milwuakee, Cornell University, expert clinical sites around the country, and you!
Your gift funds concrete steps toward treatment for ME/CFS!